CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions
To investigate the correlation between the CHADS2 score and risk of contrast-induced nephropathy (CIN), we conducted a retrospective study in patients who underwent elective percutaneous coronary intervention (PCI) and compared its accuracy with previous scoring systems. Methods: A total of 539 pati...
Main Authors: | Ruey-Hsing Chou, Po-Hsun Huang, Chien-Yi Hsu, Hsin-Bang Leu, Shao-Sung Huang, Chin-Chou Huang, Jaw-Wen Chen, Shing-Jong Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-07-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664615004155 |
Similar Items
-
Incidence, Risk Factors, and Outcomes of Contrast Associated Nephropathy following Percutaneous Coronary Intervention
by: Iqbal Wani, et al.
Published: (2020-01-01) -
Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01) -
Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
by: Jun-yi Zhang, et al.
Published: (2019-07-01) -
Original paper<br>Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice
by: Hanna Bachórzewska-Gajewska, et al.
Published: (2006-12-01) -
The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Yan G, et al.
Published: (2021-04-01)